Overweight at 50 Tied to Earlier Alzheimer’s

By Amy Norton

Overweight at 50 Tied to Earlier Alzheimer'sAvoiding middle-age spread could be one way to delay the onset of dementia, a new study hints.

Researchers found that among 142 elderly adults with Alzheimer’s disease, those who were overweight at age 50 tended to develop the memory-robbing disorder earlier.

On average, the study participants were 83 years old when diagnosed with Alzheimer’s. But that age of onset varied according to people’s weight at age 50: For each unit increase in body mass index (BMI), Alzheimer’s set in about seven months earlier, on average.

Other studies have found that obesity may boost the risk of developing Alzheimer’s. But this research suggests it also speeds the onset, said senior researcher Dr. Madhav Thambisetty, of the U.S. National Institute on Aging.

“We think that’s important because one of the goals in Alzheimer’s research is to find ways to delay the onset of the disease,” Thambisetty said.

The study, published online September 1, 2015 in the journal Molecular Psychiatry, does not prove that obesity, itself, hastens Alzheimer’s.

However, obese adults often have health conditions that have been linked to an increased Alzheimer’s risk, such as high blood pressure, high cholesterol and diabetes.

In the study, Thambisetty’s team did account for those conditions — plus smoking — and found that a higher BMI at age 50 was still connected to earlier Alzheimer’s onset.

What’s more, brain autopsies showed that Alzheimer’s patients who’d been heavier in middle age generally had more brain “tangles” — twisted strands of protein that build up in the brains of people with the disease.

It’s not clear, however, whether those brain abnormalities are the reason for the earlier Alzheimer’s, Thambisetty said. Plus, he noted, there were some factors that his team could not account for — such as the quality of people’s diets.

That’s important because research has suggested, for instance, that a Mediterranean diet — rich in vegetables, fruit, and “good” fats from olive oil and fish — may help stave off Alzheimer’s, according to the Institute on Aging.

There is also evidence that exercise, both physical and mental, could have a protective effect.

Still, another Alzheimer’s researcher said the bottom line is this: The same factors that affect heart health may also affect brain health.

“This study confirms that there is a bundle of risk factors for Alzheimer’s that we can modify,” said Dr. Malaz Boustani, director of the Center for Brain Care Innovation at Indiana University and a spokesman for the American Federation on Aging Research.

The study findings come from a long-term review of nearly 1,400 older adults who were free of dementia at the outset. Just over 10 percent were eventually diagnosed with Alzheimer’s.

The study can’t answer the question of why higher BMI — a calculation of body fat — in middle age was linked to earlier Alzheimer’s onset or to higher levels of brain tangles, Thambisetty said.

But, it’s “plausible” that obesity, itself, contributed, he said.

Many studies, he noted, have found that obesity can cause a state of chronic inflammation in the body, including the brain. And that inflammation might worsen the brain damage seen in people with Alzheimer’s.

While questions remain, there are already many health reasons to avoid mid-life obesity, Boustani pointed out. “This study gives people yet another reason to try to reduce their BMI,” he said.

Of course, he added, losing excess weight at the age of 40 or 50 is “no walk in the park.”

Thambisetty agreed, adding that’s why preventing obesity in the first place is key.

“We know that maintaining a healthy weight throughout life is important for a variety of reasons,” he said. “This study suggests that a healthy BMI, as early as mid-life, could also help delay Alzheimer’s disease.”

Source: http://consumer.healthday.com/cognitive-health-information-26/alzheimer-s-news-20/heavier-weight-in-middle-age-tied-to-earlier-alzheimer-s-702824.html

Related Online CEU Courses:

Lewy Body Dementia: Information for Patients, Families, and Professionals is a 1-hour online continuing education (CE/CEU) course that explains what is known about the different types of LBD and how they are diagnosed. Most importantly, it describes how to treat and manage this difficult disease, with practical advice for both people with LBD and their caregivers.

The Dementias: Hope through Research is a 1-hour online continuing education (CE/CEU) course that describes specific types of dementia and how the disorders are diagnosed and treated, including drug therapy.

Alzheimer’s Disease Progress Report: Intensifying the Research Effort is a 3-hour online continuing education (CE/CEU) course that reviews basic mechanisms and risk factors of AD and details recent research findings.

Alzheimer’s: Unraveling the Mystery is a 3-hour online CEU course that describes the risk factors for Alzheimer’s disease, effective steps for prevention, strategies for diagnosing and treating Alzheimer’s disease, and the search for new treatments.

Clinician’s Guide to Understanding, Evaluating & Treating Obesity – This course is designed to help clinicians enhance their working knowledge of the etiology and treatment of obesity. Case studies will elucidate different aspects of treatment.

Professional Development Resources is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Professional Development Resources maintains responsibility for all programs and content. Professional Development Resources is also approved by the National Board of Certified Counselors (NBCC); the Association of Social Work Boards (ASWB); the American Occupational Therapy Association (AOTA); the American Speech-Language-Hearing Association (ASHA); the Commission on Dietetic Registration (CDR); the California Board of Behavioral Sciences; the Florida Boards of Social Work, Mental Health Counseling and Marriage and Family Therapy, Psychology & School Psychology, Dietetics & Nutrition, Speech-Language Pathology and Audiology, and Occupational Therapy Practice; the Ohio Counselor, Social Worker & MFT Board; the South Carolina Board of Professional Counselors & MFTs; and by theTexas Board of Examiners of Marriage & Family Therapists and State Board of Social Worker Examiners.

The Dementias: Hope through Research Approved for ASHA Credit

By the National Institute on Aging (NIA)

A diagnosis of dementia can be frightening for those affected by the syndrome, their family members, and caretakers. Learning more about dementia can help.

The Dementias: Hope through ResearchThe Dementias: Hope through Research is a new 1-hour online continuing education (CE/CEU) that provides a general overview of dementia and specific types of dementia along with their signs and symptoms; lists risk factors that can increase a person’s chance of developing one or more kinds of dementia; describes how the disorders are diagnosed and treated, including drug therapy; and offers highlights of research that is supported by the National Institute of Neurological Disorders and Stroke and the National Institute on Aging, both part of the National Institutes of Health (NIH). Course #10-75 | 2012 | 20 pages | 10 posttest questions

Professional Development Resources is approved by the Continuing Education Board of the American Speech-Language-Hearing Association (ASHA Provider #AAUM) to provide continuing education activities in speech-language pathology and audiology.

This course is offered for .1 ASHA CEUs (Introductory level, Professional area).

ASHA credit expires 5/31/2017. ASHA CEUs are awarded by the ASHA CE Registry upon receipt of the quarterly completion report from the ASHA Approved CE Provider. Please note that the completion date that appears on ASHA transcripts is the last day of the quarter regardless of when the course was completed.

Professional Development Resources is also approved by the Florida Board of Speech-Language Pathology and Audiology and is CE Broker compliant (courses are reported within one week of completion).

The Dementias: Hope through Research – New Online CE Course

By the National Institute on Aging (NIA)

The Dementias: Hope through ResearchA diagnosis of dementia can be frightening for those affected by the syndrome, their family members, and caretakers. Learning more about dementia can help. This new continuing education (CE/CEU) course provides a general overview of various types of dementia, describes how the disorders are diagnosed and treated, and offers highlights of research that is supported by the National Institute of Neurological Disorders and Stroke and the National Institute on Aging, both part of the National Institutes of Health (NIH). Click here to learn more.

CE Credit: 1 Hour
Target Audience: Psychologists | Counselors | Social Workers | Occupational Therapists | MFTs | Nutritionists & Dietitians
Learning Level: Intermediate
Course Type: Online
Cost: $19

The Basics of Dementia

Dementia is the loss of cognitive functioning, which means the loss of the ability to think, remember, or reason, as well as behavioral abilities, to such an extent that it interferes with a person’s daily life and activities. Signs and symptoms of dementia result when once-healthy neurons (nerve cells) in the brain stop working, lose connections with other brain cells, and die. While everyone loses some neurons as they age, people with dementia experience far greater loss. Researchers are still trying to understand the underlying disease processes involved in the disorders.

According to the National Institute of Neurological Disorders and Stroke, “Age is the primary risk factor for developing dementia. For that reason, the number of people living with dementia could double in the next 40 years with an increase in the number of Americans who are age 65 or older—from 40 million today to more than 88 million in 2050. Regardless of the form of dementia, the personal, economic, and societal demands can be devastating.”

Types of Dementia

Various disorders and factors contribute to the development of dementia. Neurodegenerative disorders such as Alzheimer’s disease (AD), frontotemporal disorders, and Lewy body dementia result in a progressive and irreversible loss of neurons and brain functions. Currently, there are no cures for these progressive neurodegenerative disorders.

However, other types of dementia can be halted or even reversed with treatment. Normal pressure hydrocephalus, for example, often resolves when excess cerebrospinal fluid in the brain is drained via a shunt and rerouted elsewhere in the body. Cerebral vasculitis responds to aggressive treatment with immunosuppressive drugs. In rare cases, treatable infectious disorders can cause dementia. Some drugs, vitamin deficiencies, alcohol abuse, depression, and brain tumors can cause neurological deficits that resemble dementia. Most of these causes respond to treatment.

Causes of Dementia

In many cases, the causes of dementia are unknown at the present time. However, some dementias have identifiable causes such as gene mutation, head injury, Parkinson’s disease, vascular injuries, stroke, other brain diseases such as Huntington’s disease environmental factors like poisoning or substance abuse, and infectious diseases like HIV.

Risk factors include age, alcohol use, atherosclerosis, diabetes, Down syndrome, genetics, hypertension, mental illness, and smoking.

Treatment and Management

Some dementias are treatable. However, therapies to stop or slow common neurodegenerative diseases such as AD have largely been unsuccessful, though some drugs are available to manage certain symptoms. Most drugs for dementia are used to treat symptoms in AD. These drugs are sometimes used to treat other dementias as well. These drugs can temporarily improve or stabilize memory and thinking skills in some people by increasing the activity of the cholinergic brain network. They may also prevent declines in learning and memory. None of these drugs can stop or reverse the course of the disease.

This new CE course The Dementias: Hope through Research provides a general overview of dementia and specific types of dementia along with their signs and symptoms; lists risk factors that can increase a person’s chance of developing one or more kinds of dementia; describes how the disorders are diagnosed and treated, including drug therapy; and offers highlights of ongoing research.

Currently, there are no cures for the common dementias caused by progressive neurodegeneration, including AD, frontotemporal disorders, and Lewy body dementia. However, some forms of dementia are treatable. A better understanding of dementia disorders, as well as their diagnosis and treatment, will make it possible for affected individuals and their caretakers to live their lives more fully and meet daily challenges.

Professional Development Resources is approved by the American Psychological Association (APA); the National Board of Certified Counselors (NBCCACEP #5590); the Association of Social Work Boards (ASWB Provider #1046, ACE Program); the American Occupational Therapy Association (AOTA Provider #3159); the Commission on Dietetic Registration (CDR Provider #PR001); the CaliforniaBoard of Behavioral Sciences (#PCE1625); the Florida Boards of Social Work, Mental Health Counseling and Marriage and Family Therapy (#BAP346), Psychology & School Psychology (#50-1635), Dietetics & Nutrition (#50-1635), and Occupational Therapy Practice (#34); the Ohio Counselor, Social Worker & MFT Board (#RCST100501); the South Carolina Board of Professional Counselors & MFTs (#193); and the Texas Board of Examiners of Marriage & Family Therapists (#114) and State Board of Social Worker Examiners (#5678).

Enhanced by Zemanta